Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria.
Pathol Oncol Res. 2006;12(3):133-42. doi: 10.1007/BF02893359. Epub 2006 Sep 23.
Pathol Oncol Res. 2006.
PMID: 16998592
Free article.
Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma.
Árvai K, Nagy K, Barti-Juhász H, Peták I, Krenács T, Micsik T, Végső G, Perner F, Szende B.
Árvai K, et al. Among authors: barti juhasz h.
Pathol Oncol Res. 2012 Jul;18(3):607-14. doi: 10.1007/s12253-011-9483-7. Epub 2011 Dec 24.
Pathol Oncol Res. 2012.
PMID: 22198862
Free article.
Item in Clipboard
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.
Grisendi G, Bussolari R, Cafarelli L, Petak I, Rasini V, Veronesi E, De Santis G, Spano C, Tagliazzucchi M, Barti-Juhasz H, Scarabelli L, Bambi F, Frassoldati A, Rossi G, Casali C, Morandi U, Horwitz EM, Paolucci P, Conte P, Dominici M.
Grisendi G, et al. Among authors: barti juhasz h.
Cancer Res. 2010 May 1;70(9):3718-29. doi: 10.1158/0008-5472.CAN-09-1865. Epub 2010 Apr 13.
Cancer Res. 2010.
PMID: 20388793
Item in Clipboard
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro.
Barti-Juhasz H, Mihalik R, Nagy K, Grisendi G, Dominici M, Petak I.
Barti-Juhasz H, et al.
Haematologica. 2011 Mar;96(3):e21-2. doi: 10.3324/haematol.2010.036822.
Haematologica. 2011.
PMID: 21357712
Free PMC article.
No abstract available.
Item in Clipboard
Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.
Schwab R, Petak I, Kollar M, Pinter F, Varkondi E, Kohanka A, Barti-Juhasz H, Schönleber J, Brauswetter D, Kopper L, Urban L.
Schwab R, et al. Among authors: barti juhasz h.
Lung Cancer. 2014 Jan;83(1):109-11. doi: 10.1016/j.lungcan.2013.10.006. Epub 2013 Oct 19.
Lung Cancer. 2014.
PMID: 24192513
Item in Clipboard
Cite
Cite